ReviewClinical cancer research : an official journal of the American Association for Cancer Research2017

Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors.

Debu Tripathy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.